We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

In Anaphylaxis, Even When in Doubt, Administer Epinephrine

By HospiMedica International staff writers
Posted on 19 Aug 2015
New recommendations by a panel of experts on emergency care calls for appropriate prompt treatment, including the use of epinephrine for all severe allergic reactions.

The panel, which was convened by the American College of Allergy, Asthma and Immunology (ACAAI; Arlington Heights, IL, USA), which included allergologists and emergency physicians, examined barriers to emergency care for anaphylaxis, and discussed ways to encourage appropriate prompt treatment, agreed that epinephrine should be given to patients at risk of an anaphylactic reaction based on a previous severe reaction or to those who have had a known or suspected exposure to their allergic trigger, with or without the development of symptoms.

Another crucial message highlighted by the panel was that anyone seen for anaphylaxis in the emergency room needs to be referred to an allergist for comprehensive follow-up care and guidance for severe allergic reactions. The panel also recommended that allergists and emergency physicians continue to work in partnership, that allergists be proactive in outreach to emergency care practitioners, and that easy-to-access educational programs and materials be developed for use by emergency medical systems and emergency department practitioners in the training environment and in practice. The recommendations were published on August 6, 2015, in Annals of Allergy, Asthma and Immunology.

“Our emergency medicine colleagues told us that if patients don't fit established guidelines for anaphylaxis, there may be a reluctance in the emergency room to treat with epinephrine,” said panel chair allergist Stanley Fineman, MD, past president of the ACAAI. “Because epinephrine is the first line of defense in treating anaphylaxis, the panel agreed it should be used, even if a patient's reaction may not meet all the established criteria. The consequences for not using epinephrine when it's needed are much more severe than using it when it might not be necessary.”

“We want emergency medical personnel, as well as people who have had, or are at risk for having severe allergic reactions to know there is no substitute for epinephrine as the most important tool for combatting anaphylaxis,” added panel member allergist Paul Dowling, MD, of Children's Mercy Hospitals and Clinics (Kansas City, MO, USA). “Antihistamines and corticosteroids should not be given instead of epinephrine because they don't work fast enough.”

Anaphylaxis is a severe allergic reaction that involves a number of body systems, and can be fatal within minutes. It can occur in people with allergies to certain foods, insect stings, medications, latex, or other allergens. All published US national anaphylaxis guidelines recommend epinephrine as the first choice treatment in an acute episode. The vast majority of deaths from anaphylaxis occur in individuals who do not receive epinephrine in a timely manner.

Related Links:

American College of Allergy, Asthma and Immunology
Children's Mercy Hospitals and Clinics



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Illuminated Retractor System
HandLite

Latest Critical Care News

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants